Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02803320 · ClinicalTrials.gov registry record · NA
To Assess the Safety of a Sunscreen Product
A NA study of Sunscreening Agents, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT02803320: Completed NA study of Sunscreening Agents, sponsored by Bayer.
NCT02803320 is a NA study of Sunscreening Agents that has completed, run by Bayer. The registered enrollment target is 107 participants, above the 76-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02803320, a NA study of Sunscreening Agents, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to assess the safety and appropriateness of a sunscreen product for use on sport users, under supervised outdoor use conditions.
Primary Outcome
• "product related," • "likely product related," • "unlikely product related, or "not product related.
Conditions Studied
Interventions
- DRUG SPF 50 Y65 110 (BAY 987516)
Study Locations (1)
Florida
- - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2015-05-27 |
| Est. Completion | 2015-05-31 |
| Phase | NA |
What the finished NCT02803320 record still lists
NCT02803320 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, above the 76-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (41% higher).
The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 1 intervention - of which SPF 50 Y65 110 (BAY 987516) is the first listed.
NCT02803320 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02803320 about?
NCT02803320 is a clinical study titled "To Assess the Safety of a Sunscreen Product". The objective of this study was to assess the safety and appropriateness of a sunscreen product for use on sport users, under supervised outdoor use conditions.
What is the current status of trial NCT02803320?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2015-05-27. Estimated completion is 2015-05-31.
What conditions does trial NCT02803320 study?
This clinical trial studies the following conditions: Sunscreening Agents.
What interventions are being tested in trial NCT02803320?
The interventions under investigation include: SPF 50 Y65 110 (BAY 987516) (DRUG).
Who is sponsoring clinical trial NCT02803320?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02803320 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreening Agents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02803320's enrollment target sits among peer trials
107 2nd of 21 the highest of 21 other Sunscreening Agents trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sunscreening Agents trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Sunscreen Dispensers in Parks Visited by Teenagers
ACTIVE NOT RECRUITING · NA
-
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products
COMPLETED · NA
-
Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)
COMPLETED · NA
-
Sun Protection Factor Assay (SPF Assay 204/2016)
COMPLETED · NA
-
18794 - Human Photo Toxicity Test
COMPLETED · NA
-
Sun Protection Factor Assay
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI